1. "2018"
Formats
  1. Journal Article (3011)
  2. Meeting Abstract (1948)
  3. Book Section (206)
  4. Conference Paper (38)
  5. Book Whole (11)
  6. Editorial (4)
  7. Review (4)
  8. Miscellaneous (2)
  9. Correspondence (1)
Groups
  1. Department of Medicine (2296)
  2. Solid Tumor Oncology Division (1378)
  3. GSK Faculty (1136)
  4. Sloan Kettering Institute Postdocs (1044)
  5. Surgery (870)
  6. Center for Hematologic Malignancies (863)

More Groups

People
  1. Sergio Giralt (87)
  2. Matthew Hellmann (78)
  3. Jedd Wolchok (74)
  4. Marc Ladanyi (74)
  5. Robert Motzer (71)
  6. Nancy Lee (64)

More People

Years
  1. 2018 (5225)
Publications
  1. Journal of Clinical Oncology (562)
  2. Blood (249)
  3. Cancer Research (183)
  4. Annals of Oncology (140)
  5. International Journal of Radiation Oncology, Biology, Physics (137)
  6. Modern Pathology (127)

More Publications

Publishers
  1. Elsevier Inc. (691)
  2. American Society of Clinical Oncology (605)
  3. Springer (410)
  4. American Association for Cancer Research (299)
  5. Oxford University Press (291)
  6. American Society of Hematology (273)

More Publishers

Results (5225)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Early versus delayed initiation of salvage androgen deprivation therapy and the risk of prostate cancer-specific mortality
    Meeting Abstract

    Mahal, B. A. V.; Chen, M. H.; Renshaw, A. A.; Kantoff, P. W.; D'Amico, A. V.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Patterns of progression in bone and soft tissue following treatment with Ra-223 in metastatic castrate resistant prostate cancer (mCRPC)
    Meeting Abstract

    McNamara, M. A.; Ritz, M.; Chin, B.; Oldan, J.; Anand, A.; Oyekunle, T.; Anand, M.; Armstrong, A. J.; George, D. J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cabozantinib for metastatic castration-resistant prostate cancer (mCRPC) following docetaxel: Combined analysis of two phase III trials
    Meeting Abstract

    Pond, G. R.; Sonpavde, G.; Fizazi, K.; De Bono, J. S.; Basch, E. M.; Scher, H. I.; Smith, M. R.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Cabozantinib (C) exposure-response (ER) modeling of efficacy and safety endpoints as a function of clearance in patients (pts) with renal cell carcinoma (RCC)
    Meeting Abstract

    Jonasch, E.; Motzer, R. J.; Escudier, B.; Powles, T.; Markby, D. W.; Nielsen, J.; Lacy, S.; Choueiri, T. K.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Prostate-specific membrane antigen (PSMA) PET-CT imaging in the investigation and management of biochemical recurrence in prostate cancer
    Meeting Abstract

    Keane, F.; Ged, Y.; Greally, M.; Maher, M. A.; O'Malley, K.; McCaffrey, J.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Analysis of an online tool to explore evolving practice patterns in renal cell carcinoma (RCC)
    Meeting Abstract

    Kim, W.; Rosenthal, K.; Hutson, T. E.; Motzer, R. J.; Plimack, E. R.; Obholz, K.; Vinther, A.; Rini, B. I.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • S-TRAC trial: Sensitivity analyses of disease-free survival (DFS)
    Meeting Abstract

    George, D. J.; Pantuck, A. J.; Motzer, R. J.; Ravaud, A.; Escudier, B.; Staehler, M. D.; Serfass, L.; Krishnaswami, S.; Casey, M.; Lechuga, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Impact of new systemic therapies on overall survival (OS) of patients (pts) with metastatic castration resistant prostate cancer (mCRPC) in a hospital-based registry
    Meeting Abstract

    Francini, E.; Gray, K. P.; Shaw, G.; Evan, C.; Hamid, A.; Perry, C. E.; Kantoff, P. W.; Taplin, M. E.; Sweeney, C.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Everolimus (E) plus bevacizumab (B) is effective first-line treatment for patients (pts) with advanced renal cell carcinoma (RCC) with papillary features (PF): Results from a phase II trial
    Meeting Abstract

    Feldman, D. R.; Lee, C. H.; Molina, A. M.; Knezevic, A.; Chen, Y.; Chaim, J.; Coskey, D. T.; Ged, Y.; Tickoo, S.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Outcomes of metastatic chromophobe renal cell carcinoma (ChRCC) with sarcomatoid features (SF)
    Meeting Abstract

    Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save